- Home
- LBTYA vs ASND Comparison
LBTYA vs ASND Comparison
Compare LBTYA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- ASND
- Stock Information
- Founded
- LBTYA 2004
- ASND 2006
- Country
- LBTYA Bermuda
- ASND Denmark
- Employees
- LBTYA N/A
- ASND N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYA Telecommunications
- ASND Health Care
- Exchange
- LBTYA Nasdaq
- ASND Nasdaq
- Market Cap
- LBTYA 4.3B
- ASND 8.4B
- IPO Year
- LBTYA N/A
- ASND 2015
- Fundamental
- Price
- LBTYA $11.60
- ASND $131.57
- Analyst Decision
- LBTYA Buy
- ASND Strong Buy
- Analyst Count
- LBTYA 8
- ASND 14
- Target Price
- LBTYA $21.70
- ASND $192.07
- AVG Volume (30 Days)
- LBTYA 2.0M
- ASND 394.5K
- Earning Date
- LBTYA 02-18-2025
- ASND 02-05-2025
- Dividend Yield
- LBTYA N/A
- ASND N/A
- EPS Growth
- LBTYA N/A
- ASND N/A
- EPS
- LBTYA N/A
- ASND N/A
- Revenue
- LBTYA $7,674,500,000.00
- ASND $365,187,374.00
- Revenue This Year
- LBTYA $2.89
- ASND $9.76
- Revenue Next Year
- LBTYA N/A
- ASND $81.02
- P/E Ratio
- LBTYA N/A
- ASND N/A
- Revenue Growth
- LBTYA 3.53
- ASND 115.54
- 52 Week Low
- LBTYA $10.93
- ASND $111.09
- 52 Week High
- LBTYA $21.56
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- LBTYA 28.49
- ASND 44.98
- Support Level
- LBTYA $12.66
- ASND $127.27
- Resistance Level
- LBTYA $13.07
- ASND $141.99
- Average True Range (ATR)
- LBTYA 0.30
- ASND 5.09
- MACD
- LBTYA 0.03
- ASND -1.04
- Stochastic Oscillator
- LBTYA 0.00
- ASND 29.21
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in several telecom companies in the UK, Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.